National Registry and Cohort Study of Pulmonary Vascular Disease

Status: Recruiting
Location: See all (13) locations...
Intervention Type: Combination product
Study Type: Observational
SUMMARY

This is a observational、multicenter, prospective cohort study for patients with pulmonary hypertension (PH). The purposes of this study were to evaluate the etiology、clinical characteristics、treatment modalities, and outcomes of patients with PH;also to set up registration system of PH in China, to build a database of Chinese PH, to establish a web-based international standard data acquisition system for PH and a multicenter clinical research platform. The results of the study will provide a basis for the future national health policy for prevention and treatment of PH.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Newly diagnosed or previously diagnosed patients with PH.

• Documentation of mean pulmonary arterial pressure (mPAP) \>20 mm Hg by right heart catheterization, performed at any time prior to study enrollment.

Locations
Other Locations
China
Beijing Anzhen Hospital of Capital Medical University
RECRUITING
Beijing
China-japan Friendship Hospital
RECRUITING
Beijing
Xiangya Second Hospital, Central South University
RECRUITING
Changsha
West China Hospital, Sichuan University
RECRUITING
Chendu
Guangdong Provincial Peoples Hospital
RECRUITING
Guangzhou
Nanjing Drum Tower Hospital
RECRUITING
Nanjing
Nanjing First Hospital
RECRUITING
Nanjing
General Hospital of Northen Theater of Command
RECRUITING
Shenyang
General Hospital of Tianjin Medical University
RECRUITING
Tianjin
Tongji Hospital, Huazhong University of Science and Technology
RECRUITING
Wuhan
Zhongnan Hospital of Wuhan University
RECRUITING
Wuhan
First Affiliated Hospital of Xi'An Jiaotong University
RECRUITING
Xi'an
First Hospital of Zhengzhou University
RECRUITING
Zhengzhou
Contact Information
Primary
Shao-Liang Chen, MD, PhD
chmengx@126.com
+86-25-52271351
Backup
Jing Kan, MPH
kanjingok@126.com
+86-25-52271398
Time Frame
Start Date: 2022-03-29
Estimated Completion Date: 2028-12-30
Participants
Target number of participants: 1000
Treatments
1
All consecutive consenting patients diagnosed with PH according to specific hemodynamic criteria at participating institutions.
Related Therapeutic Areas
Sponsors
Leads: Nanjing First Hospital, Nanjing Medical University

This content was sourced from clinicaltrials.gov